Home › Transthyretin-Related Hereditary Amyloidosis › Texas › Dallas
Transthyretin-Related Hereditary Amyloidosis clinical trials in Dallas, TX
4 studies for Transthyretin-Related Hereditary Amyloidosis are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
RecruitingObservational study
- Research Site, Dallas
Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
RecruitingObservational study
- University of Texas Southwestern Medical Center, Dallas
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
RecruitingPhase 3
- University of Texas Southwestern, Dallas
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
RecruitingPhase 3
- Baylor Scott & White Research Institute, Dallas
- University of Texas Southwestern Medical Center, Dallas
Transthyretin-Related Hereditary Amyloidosis trials in other cities
- New York City, NY5 studies
- Los Angeles, CA5 studies
- Durham, NC4 studies
- San Diego, CA4 studies
- Baltimore, MD4 studies
- Philadelphia, PA4 studies
- Boston, MA4 studies
- Portland, OR4 studies
- New Haven, CT3 studies
- Chicago, IL3 studies
- Washington, DC3 studies
- Kansas City, MO3 studies
Other studies in Dallas
- Breast Cancer55 studies
- Non-Small Cell Lung Cancer52 studies
- Metastatic Cancer42 studies
- Heart Failure42 studies
- Cancer (all types)37 studies
- Prostate Cancer36 studies
- Colorectal Cancer33 studies
- Obesity30 studies
- Ovarian Cancer28 studies
- Lung Cancer27 studies
- Bladder Cancer27 studies
- Endometrial Cancer24 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.